Mount Laurel, New Jersey’s PMC Group N.A. Inc. and Lanxess Organometallics GmbH report that PMC has acquired Lanxess’ organotin specialties product line. The transaction, previously reported on Nov. 13, 2019, closed effective Dec. 30, 2019. The business included Lanxess’ global organotin catalyst, organotin specialties and intermediates product lines.
PMC Group is a U.S.-based growth oriented, diversified, global chemicals and pharmaceuticals company that serves a range of end markets, including plastics, consumer products, electronics, coatings, packaging, mining, personal care, food, automotive and pharmaceuticals. PMC operates facilities in the Americas, Europe and Asia.
LANXESS is a specialty chemicals company with sales of EUR 7.2 billion in 2018, which has its North America headquarters in the Pittsburgh area. The company has about 15,500 employees in 33 countries and is represented at 60 production sites worldwide. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives, specialty chemicals and plastics.
